You just read:

Edison Pharmaceuticals & Bambino Gesu Children's Hospital Announce Initiation of EPI-743 Phase 2 Cobalamin C Deficiency Syndrome Clinical Trial

News provided by

Edison Pharmaceuticals, Inc.

Feb 19, 2013, 12:01 EST